Angiotensin Receptor-Neprilysin Inhibition for Doxorubicin-Mediated Cardiotoxicity Time for a Paradigm Shift

被引：0
|
作者：
Hahn, Virginia S. [1 ]
Sharma, Kavita [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA
来源：
JACC: CARDIOONCOLOGY | 2020年 / 2卷 / 05期
关键词：
anthracycline; cardio-oncology; echocardiography; fibrosis; heart failure; matrix metalloproteinase; molecular imaging; neprilysin preclinical study; treatment;
D O I：
10.1016/j.jaccao.2020.10.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：788 / 790
页数：3
相关论文
共 50 条
  • [41] Angiotensin receptor-neprilysin inhibition in heart failure with preserved ejection fraction: lessons fromPARAGON-HF
    Vaduganathan, Muthiah
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (09) : 1525 - 1530
  • [42] Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
    Singh, Jagdeep S. S.
    Lang, Chim C.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 283 - 295
  • [43] Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment
    Koichi Yamamoto
    Hiromi Rakugi
    Hypertension Research, 2021, 44 : 1239 - 1250
  • [44] Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity
    Federica Maccarinelli
    Elena Gammella
    Michela Asperti
    Maria Regoni
    Giorgio Biasiotto
    Emilia Turco
    Fiorella Altruda
    Silvia Lonardi
    Laura Cornaghi
    Elena Donetti
    Stefania Recalcati
    Maura Poli
    Dario Finazzi
    Paolo Arosio
    Gaetano Cairo
    Journal of Molecular Medicine, 2014, 92 : 859 - 869
  • [45] The Acute Hemodynamic Unloading Effects of Angiotensin Receptor-Neprilysin Inhibition in Patients Receiving Intravenous Vasoactive Therapy
    Martyn, Trejeeve
    Faulkenberg, Kathleen D.
    Albert, Chonyang L.
    Randhawa, Varinder
    Donnellan, Eoin
    Il'Giovine, Zachary J.
    Menon, Venu
    Nissen, Steven E.
    Estep, Jerry D.
    Tang, W. H. Wilson
    Starling, Randall C.
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S24 - S24
  • [46] Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
    Zhu, Xiaogang
    Li, Xialing
    Zhu, Lingxuan
    Tong, Zichuan
    Xu, Xiuying
    CARDIOVASCULAR THERAPEUTICS, 2024, 2024
  • [47] Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment
    Yamamoto, Koichi
    Rakugi, Hiromi
    HYPERTENSION RESEARCH, 2021, 44 (10) : 1239 - 1250
  • [48] Neprilysin Inhibition as a PARADIGM Shift in Heart Failure Therapy
    Hsiao R.
    Greenberg B.
    Current Heart Failure Reports, 2016, 13 (4) : 172 - 180
  • [49] Angiotensin receptor-neprilysin inhibition and combination use of guideline-directed medical therapies in acute heart failure
    Tanaka, Atsushi
    Imai, Takumi
    Kida, Keisuke
    Matsue, Yuya
    Node, Koichi
    EUROPEAN JOURNAL OF HEART FAILURE, 2025, 27 (01) : 110 - 112
  • [50] Impact of angiotensin receptor-neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: A pilot study
    Nathaniel, Sangeetha
    McGinty, Shane
    Witman, Melissa A. H.
    Edwards, David G.
    Farquhar, William B.
    Hosmane, Vinay
    Wenner, Megan M.
    PHYSIOLOGICAL REPORTS, 2022, 10 (05):
12345